Log In
Print
BCIQ
Print
Print this Print this
 

Duodopa, Duopa, levodopa/carbidopa

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionLevodopa-carbidopa intestinal gel
Molecular Target Dopamine receptor ; Decarboxylase
Mechanism of ActionDecarboxylase inhibitor; Dopamine receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat advanced idiopathic Parkinson's disease (PD) in patients with severe motor fluctuations who do not respond to oral treatment; Treat advanced Parkinson's disease (PD) patients with severe motor fluctuations; Treat motor fluctuations associated with Parkinson's disease (PD); Treat Parkinson's disease (PD)
Regulatory Designation

Australia - Orphan Drug (Treat advanced idiopathic Parkinson's disease (PD) in patients with severe motor fluctuations who do not respond to oral treatment)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today